Dec 22, 2021
This week’s View looks at differences in results of the REDUCE-IT (Reduction of Cardiovascular Events With Icosapent Ethyl-Intervention Trial) and STRENGTH (Long-Term Outcomes Study to Assess Statin Residual Risk With Epanova in High Cardiovascular Risk Patients With Hypertriglyceridemia) trials and if they can...
Dec 15, 2021
This week’s View examines the clinical course and short-term outcomes of suspected myocarditis following COVID-19 vaccination in patients <21 years of age; the effect of empagliflozin in patients with heart failure across the spectrum of LVEF; and the safety and immunogenicity profiles of different COVID-19...
Dec 9, 2021
This week’s View examines whether high-grade premature ventricular contractions (PVCs) during stress testing predict mortality in asymptomatic individuals; trends in transcatheter mitral valve therapies in the United States; and key perspectives on the newly released ACC/AHA/SCAI Coronary...
Dec 1, 2021
This episode of Eagle’s Eye View examines the long-term outcomes for patients with left main CAD treated with PCI with drug-eluting stents vs. CABG; a state-of-the-art review on acute aortic syndrome; and the impact of heart disease subtypes on in-hospital mortality of patients with COVID-19.
Dec 1, 2021
This episode of Eagle’s Eye View examines direct links between distinct components of physical activity, their changes over time, and cardiorespiratory fitness rate; the rate of recurrent venous thromboembolism in patients with subsegmental pulmonary embolism managed without anticoagulation; and the effects of spinal...